학술논문
Comprehensive report of the efficacy, safety, quality of life, and work impact of Olopatadine 0.6% and Olopatadine 0.4% treatment in patients with seasonal allergic rhinitis.
Document Type
Article
Author
Source
Allergy & Asthma Proceedings; Nov/Dec2007, Vol. 28 Issue 6, p716-723, 8p, 7 Charts, 2 Graphs
Subject
Language
ISSN
10885412
Abstract
Copyright of Allergy & Asthma Proceedings is the property of OceanSide Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)